Molecular Targeted Radiosensitizers Molecular Targeted Radiosensitizers
Cancer Drug Discovery and Development

Molecular Targeted Radiosensitizers

Opportunities and Challenges

    • 119,99 €
    • 119,99 €

Description de l’éditeur

Molecular Targeted Radiosensitizers: Opportunities and Challenges provides the reader with a comprehensive review of key pre-clinical research components required to identify effective radiosensitizing drugs. The book features discussions on the mechanisms and markers of clinical radioresistance, pre-clinical screening of targeted radiosensitizers, 3D radiation biology for studying radiosensitizers, in vivo determinations of local tumor control, genetically engineered mouse models for studying radiosensitizers, targeting the DNA damage response for radiosensitization, targeting tumor metabolism to overcome radioresistance, radiosensitizers in the era of immuno-oncology, and more. Additionally, the book features discussions on high-throughput drug screening, predictive biomarkers, pre-clinical tumor models, and the influence of the tumor microenvironment and the immune system, with a specific focus on the challenges radiation oncologists and medical oncologists currently face in testing radiosensitizers in human cancers.

Edited by two acclaimed experts in radiation biology and radiosensitizers, with thirteen chapters contributed by experts, this new volume presents an in-depth look at current developments within a rapidly moving field, with a look at where the field will be heading and providing comprehensive insight into the framework of targeted radiosensitzer development. Essential reading for investigators in cancer research and radiation biology.

GENRE
Professionnel et technique
SORTIE
2020
10 août
LANGUE
EN
Anglais
LONGUEUR
375
Pages
ÉDITIONS
Springer International Publishing
TAILLE
23
Mo

Autres livres de cette série

Gene and Cellular Immunotherapy for Cancer Gene and Cellular Immunotherapy for Cancer
2022
The Unfolded Protein Response in Cancer The Unfolded Protein Response in Cancer
2019
Estrogen Receptor and Breast Cancer Estrogen Receptor and Breast Cancer
2018
Innovations for Next-Generation Antibody-Drug Conjugates Innovations for Next-Generation Antibody-Drug Conjugates
2018
Targeting the DNA Damage Response for Anti-Cancer Therapy Targeting the DNA Damage Response for Anti-Cancer Therapy
2018
Tumor Organoids Tumor Organoids
2017